Definigen Definigen is a company that provides functional disease model human cells, including hepatocytes, pancreatic beta cells, and intestinal organoids. | ![]() Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. | |||
Founding Date | Founding Date 2012 | Founding Date 2016 | Founding Date 2018 | Founding Date 2013 |
Type | Type Private | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Babraham, GB HQ | Locations Lausanne, CH HQ | Locations Seattle, US HQ Cambridge, US South San Francisco, US | Locations Cambridge, US HQ Boulder, US Cambridge, US |
Employees | Employees 26 | Employees 910% decrease | Employees 42110% increase | Employees 20816% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 840.9 m | Valuation ($) 256.5 m |
Financial | ||||
Net income | Net income N/A | Net income N/A | Net income ($266.8m) (FY, 2024) | Net income ($237.1m) (FY, 2024) |
Funding | ||||
Total funding raised | Total funding raised $ 9.1m | Total funding raised N/A | Total funding raised $ 700m | Total funding raised $ 210m |
SUN bioscience is a biotech company engineering industry-standard organoids.
View companySana Biotechnology is a company specializing in cell and gene therapy.
View companyEditas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
View company